{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:04:53Z","timestamp":1792073093262,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670760"],"award-info":[{"award-number":["81670760"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Commission of Science and Innovation Program","award":["JCYJ20170818143305472; JCYJ20170817101008912"],"award-info":[{"award-number":["JCYJ20170818143305472; JCYJ20170817101008912"]}]},{"DOI":"10.13039\/501100009019","name":"Natural Science Foundation of Shenzhen University for Overseas High-Caliber Personnel","doi-asserted-by":"publisher","award":["827000111"],"award-info":[{"award-number":["827000111"]}],"id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.neuropharm.2019.04.018","type":"journal-article","created":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T05:30:26Z","timestamp":1555738226000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R\/Akt\/GSK3\u03b2 signaling"],"prefix":"10.1016","volume":"153","author":[{"given":"Xingsheng","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2128-3794","authenticated-orcid":false,"given":"Ying","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.04.018_bib1","doi-asserted-by":"crossref","first-page":"41342","DOI":"10.1074\/jbc.M502168200","article-title":"Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by b-catenin-dependent and -indepen-dent signaling cascades involving Src\/ERK and phosphatidylinositol 3-kinase\/AKT","volume":"280","author":"Almeida","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib2","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","article-title":"Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease","volume":"91","author":"Alonso","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"13","key":"10.1016\/j.neuropharm.2019.04.018_bib3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.neuropharm.2019.04.018_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.tins.2008.07.001","article-title":"Cadherins and catenins at synapses: roles in synaptogenesis and synaptic plasticity","volume":"31","author":"Arikkath","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2019.04.018_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0896-6273(03)00718-9","article-title":"Role of beta-catenin in synaptic vesicle localization and presynaptic assembly","volume":"40","author":"Bamji","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.04.018_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0278-5846(03)00023-X","article-title":"A new view of diabetic retinopathy: a neurodegenerative disease of the eye","volume":"27","author":"Barber","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2019.04.018_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease","volume":"245","author":"Batista","year":"2018","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.neuropharm.2019.04.018_bib9","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","article-title":"Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding","volume":"10","author":"Bramblett","year":"1993","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neuropharm.2019.04.018_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.conb.2010.12.004","article-title":"Cadherin-catenin adhesion complexes at the synapse","volume":"21","author":"Brigidi","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib12","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1167\/iovs.14-16143","article-title":"High-fat diet-induced retinal dysfunction","volume":"56","author":"Chang","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2019.04.018_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2337\/diabetes.48.1.86","article-title":"Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39","volume":"48","author":"Edwards","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2019.04.018_bib14","first-page":"1557","article-title":"Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2\/Bax and Bcl-xL\/Bax ratios and reducing reactive gliosis","volume":"20","author":"Fan","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2015.12.052","article-title":"The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy","volume":"1634","author":"Hansen","year":"2016","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2019.04.018_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db15-0443","article-title":"Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes","volume":"65","author":"Hern\u00e1ndez","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2019.04.018_bib17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0959-437X(00)00231-8","article-title":"New aspects of Wnt signaling pathways in higher vertebrates","volume":"11","author":"Huelsken","year":"2001","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib20","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1167\/iovs.15-16504","article-title":"High-fat diet induces toll-like receptor 4-dependent macrophage\/microglial cell activation and retinal impairment","volume":"56","author":"Lee","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00401-007-0207-8","article-title":"Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau","volume":"113","author":"Li","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.neuropharm.2019.04.018_bib22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","article-title":"TNF-\u03b1 mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's \u03b2-amyloid oligomers in mice and monkeys","volume":"18","author":"Lourenco","year":"2013","journal-title":"Cell Metabol."},{"issue":"2","key":"10.1016\/j.neuropharm.2019.04.018_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jnc.13248","article-title":"Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db\/db mice","volume":"135","author":"Ma","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/cbf.2861","article-title":"Diet-induced obesity impairs AKT signalling in the retina and causes retinal degeneration","volume":"31","author":"Mar\u00e7al","year":"2013","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib25","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1523\/JNEUROSCI.0774-15.2016","article-title":"Tau-driven neuronal and neurotrophic dysfunction in a mouse model of early tauopathy","volume":"36","author":"Mazzaro","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer's disease","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"issue":"17","key":"10.1016\/j.neuropharm.2019.04.018_bib27","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease","volume":"31","author":"McClean","year":"2011","journal-title":"J. Neurosci."},{"issue":"33","key":"10.1016\/j.neuropharm.2019.04.018_bib28","doi-asserted-by":"crossref","first-page":"13479","DOI":"10.1073\/pnas.0702334104","article-title":"beta-Catenin regulates excitatory postsynaptic strength at hippocampal synapses","volume":"104","author":"Okuda","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00401-013-1215-5","article-title":"Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer's disease model","volume":"127","author":"Polydoro","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2016.04.052","article-title":"Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3\u03b2 pathway in an amyloid \u03b2 protein induced alzheimer disease mouse model","volume":"783","author":"Qi","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2337\/db15-1255","article-title":"Functional deficits precede structural lesions in mice with high-fat diet-induced diabetic retinopathy","volume":"65","author":"Rajagopal","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2019.04.018_bib32","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.2337\/db13-1673","article-title":"Neuroretinal dysfunction with intact blood-retinal barrier and absent vasculopathy in type 1 diabetes","volume":"63","author":"Reis","year":"2014","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.neuropharm.2019.04.018_bib33","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1172\/JCI1349","article-title":"Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans","volume":"101","author":"Schirra","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib34","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1523\/JNEUROSCI.5927-11.2012","article-title":"Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease","volume":"32","author":"Shahpasand","year":"2012","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2019.04.018_bib35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jnc.12469","article-title":"Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress","volume":"128","author":"Sharma","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib36","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bjophthalmol-2012-302005","article-title":"Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications","volume":"96","author":"Sim\u00f3","year":"2012","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.neuropharm.2019.04.018_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tem.2013.09.005","article-title":"Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives","volume":"25","author":"Sim\u00f3","year":"2014","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1522014113","article-title":"Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus","volume":"113","author":"Sohn","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib39","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1167\/iovs.11-8997","article-title":"Early neurodegeneration in the retina of type 2 diabetic patients","volume":"53","author":"van Dijk","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/hep.26272","article-title":"Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor \u03b1 through a sterol regulatory element-binding protein 1c-dependent mechanism in mice","volume":"58","author":"Wu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.neuropharm.2019.04.018_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mcn.2015.10.005","article-title":"Exendin-4 reduces tau hyperphosphorylation in type 2 diabetic rats via increasing brain insulin level","volume":"70","author":"Yang","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.04.018_bib42","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1016\/j.febslet.2012.08.025","article-title":"The microtubule associated protein syntabulin is required for glucose-stimulated and cAMP-potentiated insulin secretion","volume":"586","author":"Ying","year":"2012","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.neuropharm.2019.04.018_bib43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1530\/JME-15-0155","article-title":"GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt\/GSK3b\/b-catenin pathwayJ","volume":"55","author":"Ying","year":"2015","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.neuropharm.2019.04.018_bib44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1167\/iovs.09-4727","article-title":"Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats","volume":"52","author":"Zhang","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2019.04.018_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-018-0295-z","article-title":"GSK3\u03b2-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions","volume":"13","author":"Zhu","year":"2018","journal-title":"Mol. Neurodegener."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819301352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819301352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T12:10:26Z","timestamp":1663330226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819301352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":45,"alternative-id":["S0028390819301352"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.04.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R\/Akt\/GSK3\u03b2 signaling","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}